Flow cytometric measurements in 104 anti-T-lymphocyte globulin treatments.
Ekberg
H
H
Department of Surgery, Lund University, Malmö General Hospital, Sweden.
Persson
N H
NH
Olsson
M
M
Lundell
A
A
Bredberg
A
A
D000208:Acute Disease; D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D017252:CD3 Complex / Q000276:immunology; D002102:Cadaver; D016572:Cyclosporine / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D005260:Female; D005434:Flow Cytometry; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology* / Q000628:therapy; D006085:Graft Survival / Q000276:immunology*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000276:immunology* / Q000628:therapy; D012086:Reoperation; D012307:Risk Factors; D016176:T-Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology*
D000961:Antilymphocyte Serum; D017252:CD3 Complex; D016572:Cyclosporine